The Pneumococcal Testing market is attracting investment in point-of-care testing technologies. Faster testing near the patient can improve diagnostic access, particularly in settings where centralized laboratory services are limited. The pneumococcal testing market is projected to grow from US$ 2.26 billion in 2025 to US$ 5.76 billion by 2034, registering a CAGR of 10.97% during...